Delivery Order SPE2DB20D1100-SPE2DB25FD4Z1
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,143.19 by the Defense Logistics Agency on September 11, 2025, for the supply of Tresiba FlexTouch 100 Unit/mL 3mL insulin pens. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 12, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency (DLA) for Tresiba FlexTouch 200 Unit/mL 3mL insulin pens, with a ceiling value of $2,491.38. The award, issued on September 22, 2025, is a firm fixed-price delivery order with an ultimate completion date of September 23, 2025. This is a competitively awarded contract with no set-aside designation. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $1,424.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Tresiba FlexTouch 200 Unit/mL 3mL insulin pens. This is a non-set-aside competitive award with an ultimate completion date of July 14, 2025, and performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 8, 2025, for the supply of Insulin Lispro 100 Unit/ML pens (3ML) with a ceiling value of $1,358.28. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 9, 2025, and is being funded through the Medical Supply Chain, a defense-oriented federal agency. The contract represents a child delivery order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Tresiba FlexTouch 100 unit/mL insulin pens in 3mL quantities. This $2,146.80 firm fixed-price delivery order, with an ultimate completion date of August 1, 2025, represents a non-set-aside competitive award supporting federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for $2,491.38 to supply Tresiba FlexTouch 200 unit/mL 3mL insulin pens. This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and represents a non-set-aside competitive award. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $1,211.75 delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 Unit/ML 3ML insulin pens. This firm fixed price, non-competitive delivery order was issued on September 26, 2025, with an ultimate completion date of September 29, 2025. The order was fulfilled at the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a $1,212.81 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for Tresiba FlexTouch 100 Unit/ML 3ML insulin pens. This firm fixed price, non-set-aside contract is scheduled for completion by August 12, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $1,384.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Tresiba FlexTouch 100 Unit/ML 3ML insulin pens. This is a non-set-aside contract with an ultimate completion date of August 13, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- This delivery order, valued at $1,245.69, was awarded by the Defense Logistics Agency to AmerisourceBergen Drug Corp for the supply of Tresiba FlexTouch 200 Unit/ML 3ML insulin pens. The award was made on September 22, 2025, on a firm fixed price basis with an ultimate completion date of September 23, 2025. No set-aside designation was used in this competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD4Z1Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 17, 2025, by the Defense Logistics Agency for the supply of Tresiba FlexTouch 200 unit/mL 3mL insulin pens, with a ceiling value of $3,126.29. This is a firm fixed price, non-set-aside contract with a completion date of July 18, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award reflects AmerisourceBergen's role as a critical pharmaceutical vendor within the Defense Logistics Agency's Medical Supply Chain, supplying essential medications to support military and veteran healthcare systems. The Tresiba insulin product is a long-acting basal insulin used in diabetes management, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains. The underlying IDC vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply brand-name and generic medications, vaccines, and specialized medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 7/17/25 |